Suppr超能文献

尼曼-匹克C1携带者状态模型早期成熟阶段的神经功能障碍

Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.

作者信息

Hung Ya Hui, Walterfang Mark, Churilov Leonid, Bray Lisa, Jacobson Laura H, Barnham Kevin J, Jones Nigel C, O'Brien Terence J, Velakoulis Dennis, Bush Ashley I

机构信息

Oxidation Biology Unit, The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, 3010, Australia.

Neuropsychiatry Unit, Royal Melbourne Hospital and Melbourne Neuropsychiatry Centre, Melbourne, Victoria, 3050, Australia.

出版信息

Neurotherapeutics. 2016 Jul;13(3):614-22. doi: 10.1007/s13311-016-0427-5.

Abstract

Autosomal recessive inheritance of NPC1 with loss-of-function mutations underlies Niemann-Pick disease, type C1 (NP-C1), a lysosomal storage disorder with progressive neurodegeneration. It is uncertain from limited biochemical studies and patient case reports whether NPC1 haploinsufficiency can cause a partial NP-C1 phenotype in carriers. In the present study, we examined this possibility in heterozygotes of a natural loss-of-function mutant Npc1 mouse model. We found partial motor dysfunction and increased anxiety-like behavior in Npc1 (+/-) mice by 9 weeks of age. Relative to Npc1 (+/+) mice, Npc1 (+/-) mice failed to show neurodevelopmental improvements in motor coordination and balance on an accelerating Rotarod. In the open-field test, Npc1 (+/-) mice showed an intermediate phenotype in spontaneous locomotor activity compared with Npc1 (+/+) and Npc1 (-/-) mice, as well as decreased center tendency. Together with increased stride length under anxiogenic conditions on the DigiGait treadmill, these findings are consistent with heightened anxiety. Our findings indicate that pathogenic NPC1 allele carriers, who represent about 0.66 % of humans, could be vulnerable to motor and anxiety disorders.

摘要

NPC1功能丧失性突变的常染色体隐性遗传是尼曼-皮克病C1型(NP-C1)的病因,这是一种伴有进行性神经退行性变的溶酶体贮积症。从有限的生化研究和患者病例报告来看,尚不确定NPC1单倍剂量不足是否会在携带者中导致部分NP-C1表型。在本研究中,我们在自然功能丧失突变型Npc1小鼠模型的杂合子中检验了这种可能性。我们发现,到9周龄时,Npc1(+/-)小鼠出现了部分运动功能障碍和类似焦虑行为增加的情况。相对于Npc1(+/+)小鼠,Npc1(+/-)小鼠在加速转棒试验中未能表现出运动协调和平衡方面的神经发育改善。在旷场试验中,与Npc1(+/+)和Npc1(-/-)小鼠相比,Npc1(+/-)小鼠在自发运动活动中表现出中间表型,并且中心趋向性降低。在焦虑诱发条件下,DigiGait跑步机上的步幅增加,这些发现与焦虑加剧一致。我们的研究结果表明,占人类约0.66%的致病性NPC1等位基因携带者可能易患运动和焦虑症。

相似文献

1
Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
Neurotherapeutics. 2016 Jul;13(3):614-22. doi: 10.1007/s13311-016-0427-5.
3
Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
Mol Genet Metab. 2021 Dec;134(4):330-336. doi: 10.1016/j.ymgme.2021.11.008. Epub 2021 Nov 16.
4
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Acta Neuropathol Commun. 2016 Sep 1;4(1):94. doi: 10.1186/s40478-016-0370-z.
5
Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1.
Blood. 2014 Jan 2;123(1):51-60. doi: 10.1182/blood-2013-03-488692. Epub 2013 Nov 14.
8
AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
J Lipid Res. 2017 Mar;58(3):512-518. doi: 10.1194/jlr.M071274. Epub 2017 Jan 4.

引用本文的文献

2
Differently increased volumes of multiple brain areas in mutant mice following various drug treatments.
Front Neuroanat. 2024 Jul 16;18:1430790. doi: 10.3389/fnana.2024.1430790. eCollection 2024.
3
Age-related Loss of miR-124 Causes Cognitive Deficits Derepressing RyR3 Expression.
Aging Dis. 2022 Oct 1;13(5):1455-1470. doi: 10.14336/AD.2022.0204.
4
Neurotoxic effects of nephrotoxic compound diethylene glycol.
Clin Toxicol (Phila). 2021 Sep;59(9):810-821. doi: 10.1080/15563650.2021.1874403. Epub 2021 Jan 21.
5
Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.
Hum Gene Ther. 2021 Jun;32(11-12):589-598. doi: 10.1089/hum.2020.175. Epub 2021 Feb 22.
7
Enhanced Alcohol Preference and Anxiolytic Alcohol Effects in Niemann-Pick Disease Model in Mice.
Front Neurol. 2019 Jul 3;10:731. doi: 10.3389/fneur.2019.00731. eCollection 2019.
8
Hepatic and neuronal phenotype of NPC1 mice.
Heliyon. 2019 Mar 14;5(3):e01293. doi: 10.1016/j.heliyon.2019.e01293. eCollection 2019 Mar.
9
Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?
J Appl Genet. 2018 Nov;59(4):441-447. doi: 10.1007/s13353-018-0465-2. Epub 2018 Sep 13.
10
Current concepts in the neuropathogenesis of mucolipidosis type IV.
J Neurochem. 2019 Mar;148(5):669-689. doi: 10.1111/jnc.14462. Epub 2018 Aug 30.

本文引用的文献

3
Evaluation of gait impairment in mice subjected to craniotomy and traumatic brain injury.
Behav Brain Res. 2015 Jun 1;286:33-8. doi: 10.1016/j.bbr.2015.02.038. Epub 2015 Feb 23.
4
Niemann-Pick disease type C symptomatology: an expert-based clinical description.
Orphanet J Rare Dis. 2013 Oct 17;8:166. doi: 10.1186/1750-1172-8-166.
5
Parkinsonism syndrome in heterozygotes for Niemann-Pick C1.
J Neurol Sci. 2013 Dec 15;335(1-2):219-20. doi: 10.1016/j.jns.2013.08.033. Epub 2013 Sep 3.
9
Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin.
PLoS Genet. 2013 Apr;9(4):e1003462. doi: 10.1371/journal.pgen.1003462. Epub 2013 Apr 11.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验